<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To confirm the clinical diagnosis in individual Dutch patients with cerebral <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> with subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> (CADASIL), we performed direct sequence analysis of the abnormal gene, Notch3, in patients from 11 families without prior linkage analysis to chromosome 19 </plain></SENT>
<SENT sid="1" pm="."><plain>Eleven missense mutations involving the loss or gain of a <z:chebi fb="0" ids="32460">cysteine residue</z:chebi> were found, of which 3 are new </plain></SENT>
<SENT sid="2" pm="."><plain>Exon 4 is a mutation hotspot (9 of 11 families) </plain></SENT>
<SENT sid="3" pm="."><plain>Notch3 sequence analysis of CADASIL patients in a diagnostic laboratory is a feasible procedure to confirm the clinical diagnosis in individual patients </plain></SENT>
</text></document>